COMMUNIQUÉS West-GlobeNewswire

Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
04/09/2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with [...]
Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform
04/09/2025
NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ) -- Dear Shareholders, I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects [...]
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation
04/09/2025
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation NANTES, France – September 4, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) [...]
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur
04/09/2025
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur NANTES, France – 4 septembre 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: [...]
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation
04/09/2025
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation NANTES, France – September 4, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) [...]
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur
04/09/2025
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur NANTES, France – 4 septembre 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: [...]
Legend Senior Living Welcomes Annalisa Hahn as Senior Vice President of Sales and Marketing
04/09/2025
WICHITA, Kan., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a nationally recognized senior living provider with more than 70 residences across seven states, is pleased to announce the appointment of Annalisa [...]
Bay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease Solutions
04/09/2025
New venture philanthropy fund announces initial investments and will help guide game-changing Lyme diagnostics and therapeutics to commercialization PORTOLA VALLEY, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bay Area [...]
AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland
04/09/2025
Latest progress from lead program Ampligen for the treatment of pancreatic cancer highlighted at the International 5 th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025); Presentation [...]
PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen
04/09/2025
-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15 [...]
Really Global Launches Global Mental Health Marketplace with 2000+ Search Filters Connecting Clients to Providers in 200+ Countries
04/09/2025
Direct-pay platform eliminates insurance barriers while offering unprecedented search precision for trauma, ADHD, anxiety, and specialty care San Francisco, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Really Global today [...]
The University of Alabama and GATC Health Unveil Strategic Program to Accelerate Therapeutic Discovery and Development
04/09/2025
Combining university-led scientific research with advanced AI technology, this innovative model accelerates the transformation of academic research into commercially viable therapies IRVINE, Calif., Sept. 04, 2025 ( [...]
Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
04/09/2025
LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, [...]
Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204
04/09/2025
Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 Following Q4 2025 and [...]
Vireo Growth Inc. Comments on Recent Market Activity; Company Unaware of Any Material Change
04/09/2025
MINNEAPOLIS , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), at the request of the Canadian Investment Regulatory Organization (“CIRO”), today confirmed that [...]
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
04/09/2025
REYKJAVIK, Iceland, June 4, 2025 - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in [...]
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
04/09/2025
REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today [...]
Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option
04/09/2025
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare solutions, is [...]
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
04/09/2025
Collaboration builds upon positive results utilizing Predictive Oncology’s AI platform to identify new indications for existing drugs PITTSBURGH, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI [...]

Pages